These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8384254)

  • 21. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K; Rudolf J; Heiss WD
    J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
    Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
    Kim CK; Alavi JB; Alavi A; Reivich M
    J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.
    Mineura K; Yasuda T; Kowada M; Sakamoto T; Ogawa T; Shishido F; Uemura K
    Pediatr Neurosci; 1985-1986; 12(4-5):208-12. PubMed ID: 3039475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
    Korkmaz M; Kim EE; Wong FC; Podoloff DA
    Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480
    [No Abstract]   [Full Text] [Related]  

  • 30. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
    Rozental JM; Levine RL; Mehta MP; Kinsella TJ; Levin AB; Algan O; Mendoza M; Hanson JM; Schrader DA; Nickles RJ
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1053-60. PubMed ID: 2022505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
    Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
    Leiva-Salinas C; Schiff D; Flors L; Patrie JT; Rehm PK
    Radiology; 2017 May; 283(2):508-514. PubMed ID: 28234553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
    DeLaPaz RL; Patronas NJ; Brooks RA; Smith BH; Kornblith PL; Milam H; Di Chiro G
    AJNR Am J Neuroradiol; 1983; 4(3):826-9. PubMed ID: 6308993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How useful are microsurgical operations in the treatment concept for glioblastoma multiforme].
    Stummer W; Tonn JC
    MMW Fortschr Med; 2004 Apr; 146(14):28-30. PubMed ID: 15344748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.